Showing 206 results

Filters Content type: News, Editors' picks Topic: People with limited treatment options

HIV treatment for people who have a strain of HIV that is resistant to multiple drug classes or who cannot take other HIV medications.

People with limited treatment options

ICAAC: Tipranavir / ritonavir superior to other boosted PIs in salvage therapy

News
2 November 2004
People with limited treatment options

ICAAC: When to use T-20: new analysis shows risk of leaving it too late

News
31 October 2004
People with limited treatment options

Role for T-20 in pregnancy, says study

News
13 September 2004
People with limited treatment options

Poor levels of T-20 seen in semen of HIV-positive men

News
9 September 2004
People with limited treatment options

Keeping viral load below 20,000 copies/ml still beneficial, even after HIV rebound

News
7 September 2004
People with limited treatment options

Second major study shows rise in drug resistance is not increasing AIDS or death risk

News
5 August 2004
People with limited treatment options

Two-year data continue to show promise for T-20

News
13 July 2004
People with limited treatment options

Boosted dual PI salvage regimen safe, effective but high pill burden an issue

News
5 July 2004
People with limited treatment options

Stopping NNRTIs in drug-resistant patients does not alter viral loads or CD4 cell counts

News
28 June 2004
People with limited treatment options

Treatment failure due to drug resistance not a major cause of death

News
25 June 2004
People with limited treatment options

Tipranavir access expanded, but doctors warned on double boosted PI regimens

News
15 June 2004
People with limited treatment options

Boosted PIs superior to no PIs as salvage therapy in highly PI-experienced

News
24 April 2004
People with limited treatment options

Gilead abandons research on salvage drug

News
28 January 2004
Treatment interruptions

Treatment interruptions in salvage therapy: latest

News
5 March 2001